Drugs.com - Pharma Industry News

Acalabrutinib-Venetoclax Prolongs Survival in Previously Untreated Leukemia

FRIDAY, Feb. 21, 2025 -- For patients with previously untreated chronic lymphocytic leukemia (CLL), fixed-duration acalabrutinib-venetoclax with or without obinutuzumab significantly prolongs progression-free survival compared with...

Feb 21, 2025 - 21:45
 0
Acalabrutinib-Venetoclax Prolongs Survival in Previously Untreated Leukemia
FRIDAY, Feb. 21, 2025 -- For patients with previously untreated chronic lymphocytic leukemia (CLL), fixed-duration acalabrutinib-venetoclax with or without obinutuzumab significantly prolongs progression-free survival compared with...
Read More

Tags:

Previous Article

Epidural Steroid Injections Reviewed for Radicular Pain, Spinal Stenosis

Next Article

The twofold challenge of an older population — and how systems are adapting

Related Posts

Benzoyl Peroxide Formulation Characteristics Explain Variation in Benzene Levels

Benzoyl Peroxide Formulation Characteristics Explain Va...

Feb 19, 2025  0

Physical Activity Linked to Attenuation of Colon Cancer Survival Disparity

Physical Activity Linked to Attenuation of Colon Cancer...

Feb 24, 2025  0

2019 to 2020 Saw 17.9 Percent Decrease in Ophthalmic Procedures in Seniors

2019 to 2020 Saw 17.9 Percent Decrease in Ophthalmic Pr...

Feb 18, 2025  0